David M. Stack - Apr 28, 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
CEO and Chairman, Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Apr 28, 2022
Transactions value $
$243,225
Form type
4
Date filed
5/2/2022, 06:34 PM
Previous filing
Apr 5, 2022
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Options Exercise $243K +22.5K +15.46% $10.81 168K Apr 28, 2022 Direct F1
holding PCRX Common Stock 97.3K Apr 28, 2022 By Three Colleens Investment, LLC F2
holding PCRX Common Stock 18.6K Apr 28, 2022 By Stack Schroon Mohawk FLP F2
holding PCRX Common Stock 315 Apr 28, 2022 LCK Investment LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -22.5K -100% $0.00* 0 Apr 28, 2022 Common Stock 22.5K $10.81 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2 Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
F3 The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.